KAREN HEMANS: Open Payments
NPI 1699259846 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 21 payments from 11 companies in 2025. Trend: 2023 $628 · 2024 $414 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation | 2 | $188 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| ABBVIE INC. | 3 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boston Scientific Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: AQUABEAM ROBOTIC SYSTEM, PLUVICTO, BOTOX, ORGOVYX, GEMTESA, AMS 700, Nubeqa, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
